DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
Independent, dietitian-reviewed guide to the best longevity supplements for 2026 — NAD+ boosters, Urolithin A, NMN. We sell nothing and take $0 for placement.
Independent. We sell nothing we review — affiliate links never change our scores.
The standout in each category, by our 6-axis scores. Tap a pick to jump to its full breakdown.

Thorne is a top-tier, NSF-certified supplement brand whose flagship longevity product, ResveraCel, reliably raises cellular NAD+ via nicotinamide riboside. The chemistry is real, but human evidence that it slows aging or extends lifespan does not yet exist. Worth it for quality-obsessed buyers who treat it as a bet, not a proven anti-aging cure.
We score all 5 longevity products we track on the same six-axis rubric and rank every one of them here — including the lower scorers. Nothing is hidden or bumped up for paying us.
Every product here is scored on the same six-criteria rubric, fact-checked against authoritative sources (FDA, PubMed, clinical guidelines), and reviewed by a licensed clinician. We make nothing we review, and affiliate links never change a ranking. Full methodology →
What matters most: no pill has been proven to extend human lifespan, and supplements are not FDA-approved for "longevity." The strongest evidence for living longer and healthier still comes from exercise, diet, sleep, and not smoking — so treat any longevity supplement as a small, optional add-on, prioritize the few ingredients with real human data (omega-3, vitamin D if deficient, urolithin A for muscle), and buy only NSF- or USP-verified products.
"Longevity supplements" is a marketing umbrella, not a regulated category. The products grouped here claim to slow biological aging, extend "healthspan" (years lived in good health), or target the so-called hallmarks of aging — cellular processes that decline as we get older. Most fall into a few mechanistic buckets:
The crucial framing for any buyer: a plausible mechanism in a petri dish or a mouse is not proof of benefit in humans. Aging compounds reliably extend lifespan in worms, flies, and mice far more often than they show measurable benefit in people.
Honest labeling of evidence strength matters more here than in almost any other supplement category, because the marketing routinely outruns the data.
Omega-3 fatty acids — moderate evidence (for specific outcomes, not lifespan). The VITAL trial randomized 25,871 U.S. adults (men ≥50, women ≥55) to 1 g/day marine omega-3 or placebo. It did *not* reduce the primary endpoints of major cardiovascular events or total invasive cancer overall, though there were signals in some secondary analyses and subgroups (Manson et al., *NEJM* 2019; PMID: 30415637). So omega-3 has real, large-scale human data — but it did not prove a longevity benefit in a general population.
Vitamin D — moderate evidence, mostly in deficiency. Also tested in VITAL (2,000 IU/day), vitamin D did not significantly reduce total invasive cancer incidence or cardiovascular events, though there was a non-significant signal for reduced cancer *mortality* with longer latency. The NIH Office of Dietary Supplements and the VITAL investigators conclude there is no clear benefit for people who are not deficient. Correcting a documented deficiency is worthwhile; megadosing for "longevity" is not supported.
Urolithin A — moderate (for muscle/mitochondrial endpoints). A randomized controlled trial of 88 sedentary, overweight middle-aged adults (Singh et al., *Cell Reports Medicine* 2022) found that 4 months of urolithin A (500 or 1,000 mg/day) improved muscle strength and raised expression of skeletal-muscle mitophagy/mitochondrial proteins, though it missed its primary endpoint of peak power output. A separate trial in older adults (*JAMA Network Open* 2022) likewise showed improved muscle endurance and mitochondrial biomarkers. These are among the better-designed human longevity-adjacent trials — but the outcomes were muscle function, not lifespan or all-cause mortality.
NMN and NR — limited. Multiple human trials confirm these reliably raise blood NAD+ levels in a dose-dependent way and appear safe over months of use. Beyond that, results are inconsistent: some trials report modest improvements in things like vascular stiffness, muscle measures, or metabolic markers, while many show no clear clinical benefit. The mechanism is sound and safety data are reassuring, but human efficacy for aging is unproven. (Note: the FDA's stance on NMN's status as a lawful dietary ingredient has been contested, which is one reason availability fluctuates.)
Spermidine — limited. Observational data are intriguing — a 20-year follow-up of 829 adults in northern Italy (the Bruneck Study) linked higher dietary spermidine intake with lower all-cause mortality — but observational diet studies cannot prove causation. The 12-month randomized SmartAge trial (100 older adults with subjective cognitive decline) found supplementation (~0.9 mg spermidine/day) safe but did not improve memory or biomarkers versus placebo. Larger trials at higher doses are needed.
Resveratrol — limited and inconsistent. Despite years of hype, human trials have been disappointing and contradictory. Bioavailability is poor, and benefits seen in cells or mice have not translated reliably to people.
Metformin and rapamycin — unproven for aging; prescription only. Metformin is FDA-approved for type 2 diabetes (approved in the U.S. in 1995, after decades of use in Europe), and rapamycin (sirolimus) is approved for transplant immunosuppression — neither is approved for aging. The TAME trial (Targeting Aging with Metformin), led by Dr. Nir Barzilai, was designed to test whether metformin delays age-related disease but has faced funding delays. Taking these off-label for longevity is experimental and carries real risks (GI effects and B12 depletion with metformin; immune and metabolic effects with rapamycin).
The strongest "longevity intervention" of all is not a supplement. Regular physical activity, a predominantly whole-food diet, adequate sleep, not smoking, and managing blood pressure and metabolic health have the deepest evidence for extending healthy life. (Notably, the DO-HEALTH trial of 2,157 adults aged 70+ found that vitamin D, omega-3, *and* a simple home strength-exercise program each failed to improve its primary endpoints — blood pressure, fractures, physical performance, infection, or cognition — over 3 years; only exploratory analyses hinted at smaller effects. That underscores how hard it is to demonstrate benefit even for sensible interventions.) No pill substitutes for the fundamentals.
If you decide to try a longevity supplement as an optional add-on, use these criteria:
Most of the studied compounds (NMN, NR, urolithin A, spermidine, omega-3, vitamin D) have been well tolerated in trials lasting months, but "generally safe in healthy adults" is not the same as "safe for you."
Talk to a doctor or pharmacist first if you: take prescription medications (especially blood thinners, blood-pressure, or diabetes drugs), are pregnant or breastfeeding, have liver or kidney disease, have cancer or a cancer history, or are scheduled for surgery. Supplements are not regulated like drugs, so contamination and undisclosed interactions are genuine risks — bring the actual label to the appointment.
It may be reasonable for: generally healthy adults who already have the fundamentals handled (exercise, diet, sleep, no smoking) and want to experiment with a single, well-studied ingredient at the studied dose, with clear expectations and a small budget. Correcting a *documented* deficiency (e.g., low vitamin D or low dietary omega-3) is the most defensible use.
You should probably skip it if: you're hoping a pill will offset poor lifestyle habits (it won't), you're on a tight budget (the money is better spent on good food, a gym membership, or sleep), you take multiple medications, or you'd be buying high-priced multi-ingredient "anti-aging" stacks based on influencer hype. There is no evidence these benefit longevity or overall health in people who aren't deficient.
HealthVetted is independent: we charge $0 for placement and sell nothing, so rankings can't be bought. For this category we weight third-party testing (NSF/USP), dose-matching to published human RCTs, ingredient transparency, the honesty of marketing claims, value per studied dose, and the strength of evidence behind each ingredient — discounting animal-only or mechanism-only support. Full criteria, scoring, and conflict-of-interest policy are on our [methodology page](/methodology).
Do any supplements actually make you live longer? No supplement has been proven to extend human lifespan in clinical trials. A few ingredients show benefits on specific health markers (e.g., urolithin A on muscle endurance; omega-3 on certain cardiovascular subgroups), but "longer life" itself remains unproven. The interventions with the strongest evidence for a longer, healthier life are exercise, diet, sleep, and not smoking.
Is NMN or NR worth it for anti-aging? They reliably raise NAD+ levels and appear safe over months of use, but human evidence for actual anti-aging or longevity benefits is limited and inconsistent. Treat them as low-priority experiments, not proven interventions — and note their regulatory status in the U.S. has been contested, which affects availability.
Are these supplements FDA-approved? No. The FDA does not approve dietary supplements for safety or effectiveness before they're sold. Manufacturers are responsible for their own claims. That's why independent NSF or USP verification is the practical quality check — though it confirms purity and dosing accuracy, not that the product extends life.
Should I take metformin or rapamycin for longevity like I've seen online? These are prescription drugs not approved for aging. Using them off-label for longevity is experimental, carries real side effects and interactions, and should only be considered with a physician. The TAME trial was designed to test metformin's anti-aging potential but has not delivered the answer.
What's the single best thing I can do for longevity? Build the fundamentals first: regular physical activity (including strength training), a mostly whole-food diet, adequate sleep, not smoking, and keeping blood pressure and metabolic health in range. If you're deficient, correcting vitamin D or omega-3 intake is the most evidence-based supplement step — everything else is optional and unproven.
| # | Product | Active ingredient | Starting price | FDA status | Score | |
|---|---|---|---|---|---|---|
| 1 | Thorne | — | Best ·$25/mo | supplement | Top ·7.8 | See offer → |
| 2 | Elysium Basis | Nicotinamide riboside (250 mg) + pterostilbene (50 mg) | $50/mo | supplement | 7.5 | See offer → |
| 3 | Timeline Mitopure (Urolithin A) | Urolithin A (Mitopure), 500 mg/day | $95/mo | supplement | 7.3 | See offer → |
| 4 | Tru Niagen | — | $40/mo | supplement | 7.2 | See offer → |
| 5 | Wonderfeel Younger (Youngr NMN) | Nicotinamide mononucleotide (900 mg/day) + trans-resveratrol, ergothioneine, hydroxytyrosol, vitamin D3 | $73/mo | supplement | 6.7 | See offer → |
Highest combined score across six axes. Practitioner-grade supplements and home tests

Practitioner-grade supplements and home tests
Excels at safetyThorne is a top-tier, NSF-certified supplement brand whose flagship longevity product, ResveraCel, reliably raises cellular NAD+ via nicotinamide riboside. The chemistry is real, but human evidence that it slows aging or extends lifespan does not yet exist. Worth it for quality-obsessed buyers who treat it as a bet, not a proven anti-aging cure.

The NAD+ booster with its own published human trial
Excels at safetyBasis is the closest thing to a 'evidence-first' NAD+ supplement: it costs more than commodity NR powders, but you are paying for a company that ran and published its own human trial showing the product actually raises NAD+.

Clinically studied Urolithin A for mitochondrial health
Excels at trustMitopure is the most clinically validated product in the longevity supplement aisle, with several randomized trials on the exact compound. It is also one of the most expensive, and the proven benefits are about muscle and mitochondrial function, not extending lifespan.

Daily NAD+ support via nicotinamide riboside
Excels at safetyTru Niagen is a nicotinamide riboside (Niagen) supplement that reliably raises blood NAD+ levels (about 51% at the 300mg dose in a randomized trial) and has a strong safety record. But proven downstream anti-aging benefits in humans remain limited: trials show no clear gains in insulin sensitivity, muscle, or blood pressure. It is a safe, well-studied biomarker booster with an unproven longevity payoff.
Why it ranks lower weakest on effectiveness.

900 mg NMN plus longevity cofactors in one formula
Excels at user experienceWonderfeel Younger is a polished, doctor-formulated NMN product that bundles several longevity cofactors into one capsule. You pay a premium for the formulation and brand story, not for product-specific clinical proof.
Why it ranks lower weakest on value — At ~$73-$88/month it is one of the pricier NMN products; commodity NMN is far cheaper per gram..
What the actual human evidence says about the key active ingredients in this category — including where it’s strong and where it’s thin.
Gut-derived metabolite that stimulates mitophagy (clearance of damaged mitochondria) to support mitochondrial and muscle health.
Among longevity actives, urolithin A has some of the better human RCT data. A 4-month randomized trial in older adults (ages 65-90) found 1000 mg/day significantly improved skeletal-muscle endurance (contractions to fatigue) versus placebo, alongside improved mitochondrial gene-expression biomarkers. A separate RCT in middle-aged adults reported ~12% gains in muscle strength and improved aerobic endurance. Effects on strength are modest and not universally replicated, but tolerability is good.
Mitochondrial electron-transport cofactor and lipophilic antioxidant; declines with age.
CoQ10 has the only longevity-relevant mortality data here, though confounded by co-supplementation. In the Swedish KiSel-10 RCT, 200 mg/day CoQ10 plus 200 ug selenium for 4 years in healthy elderly reduced cardiovascular mortality, with benefits persisting at 10- and 12-year follow-up (12-yr HR ~0.59). Because selenium was co-administered, CoQ10's independent contribution is uncertain, and the cohort was selenium-low. CoQ10 also has established benefit in heart failure but is not proven to extend lifespan.
NAD+ precursor intended to restore age-related decline in cellular NAD+.
Human RCTs consistently confirm NR is safe and raises blood NAD+ (often 40-90%, up to ~2.6-3x at high doses). The problem is downstream benefit: trials repeatedly fail to translate NAD+ elevation into clinical gains. A 24-week long-COVID RCT at 2000 mg/day tripled NAD+ but did not improve cognition, fatigue, sleep, or mood versus placebo, and a meta-analysis found minimal benefit for muscle in older adults. Evidence for actual longevity or function endpoints is weak.
NAD+ precursor one step closer to NAD+ than NR; aimed at restoring NAD+ pools.
Like NR, human trials show NMN (150-1200 mg/day) safely and dose-dependently raises blood NAD+. Functional benefits are small and inconsistent: a 12-week RCT in older men (250 mg/day) raised NAD+ and showed only nominal gait-speed and grip-strength improvements with no change in muscle mass. A systematic review of 10 RCTs (437 patients) found physical-performance improvements were non-significant overall. NMN is well tolerated, but evidence for anti-aging outcomes remains preliminary.
Polyphenol and putative sirtuin (SIRT1) activator; popularized by the 'red wine' longevity hypothesis.
Despite its longevity reputation, human evidence is mixed and there is no lifespan or healthspan-extension data in people. A meta-analysis of 11 RCTs found resveratrol improved glucose control and insulin sensitivity in people with diabetes but had no effect on glycemic measures in non-diabetic individuals. Other meta-analyses report small cardiometabolic improvements, but findings are inconsistent across endpoints. Bioavailability is poor, and benefits, where present, are modest and condition-specific rather than anti-aging.
Naturally occurring polyamine that induces autophagy; epidemiologically linked to lower mortality.
Spermidine's human RCT evidence is thin and largely negative for hard endpoints. The phase-2b SmartAge trial randomized 100 older adults with subjective cognitive decline to ~0.9 mg/day spermidine (wheat-germ extract) for 12 months and found no improvement in memory versus placebo (adjusted effect -0.03). Authors noted the dose may have been too low. Observational data associate higher dietary spermidine with lower mortality, but causation is unproven and intervention evidence is preliminary.
Plant flavonoid investigated as a senolytic to clear senescent ('zombie') cells.
Fisetin's senolytic longevity claims rest almost entirely on mouse data, where it cleared senescent cells and extended lifespan. Human evidence is very limited: trials such as AFFIRM-LITE (intermittent 20 mg/kg/day) and osteoarthritis/COVID studies are small, mostly pilot-stage, and results are only beginning to report. As of now there are no robust published RCTs demonstrating that fisetin extends healthspan or improves aging outcomes in humans. Treat longevity claims as unproven.
No supplement has been shown to extend human lifespan, and by law none can claim to. The strongest products here have human trials measuring *surrogate* outcomes — higher blood NAD+, better muscle endurance, improved biomarkers — not proven additional years of life. Much of the field still rests on cell and animal studies. Treat these as tools that may support healthy aging, not as a proven anti-aging cure, and judge each by its own human evidence.
They are regulated as dietary supplements, not drugs. The FDA does *not* review supplements for safety or effectiveness before they reach shelves; it acts mainly after problems surface. Some ingredients carry extra nuance — Urolithin A has FDA GRAS (Generally Recognized As Safe) status, while NMN's status as a lawful supplement has been contested. Favor brands with third-party testing (NSF, USP, or independent COAs) and transparent labels, since quality and dosing aren't guaranteed by regulators.
NAD+ boosters (nicotinamide riboside or NMN) aim to raise NAD+, a coenzyme central to cellular energy and repair that drops with age. NR and NMN are related precursors that take slightly different paths to the same molecule. Urolithin A works by a separate mechanism — promoting mitophagy, the cell's recycling of worn-out mitochondria — and is studied mostly for muscle endurance and strength. Because the pathways differ, some people use them for complementary, not overlapping, goals.
It ranges widely. Generic NR or NMN powders can cost just a few dollars a month, while branded, clinically-studied formulas often run roughly $50–$125 monthly. You're typically paying more for products with their own published human trials, third-party testing, and standardized dosing. Higher price doesn't guarantee a better result, so weigh cost against the strength of each product's evidence and whether the dose matches what was actually tested in trials.
In published trials the NAD+ precursors and Urolithin A here were generally well tolerated, with mostly mild effects like digestive upset. But long-term safety data is limited, supplements can interact with medications, and they aren't appropriate for everyone — including people who are pregnant or breastfeeding, have a medical condition, or take prescription drugs. Because these aren't pre-screened by the FDA for safety, check with your clinician or pharmacist first, especially if you take other medications.
We score each product on six axes — effectiveness, safety, value, accessibility, user experience, and trust — weighting human trial evidence most heavily and giving credit for third-party testing and dosing that matches the studied amount. A registered dietitian reviews our work. We accept $0 for placement and sell no products, so an affiliate link never moves a score or softens a safety caveat. Rankings are dynamic and update as new evidence, formulas, and prices emerge.